Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

5.37
-0.2700-4.79%
Post-market: 5.540.1718+3.20%19:42 EDT
Volume:1.68M
Turnover:9.04M
Market Cap:692.32M
PE:-1.74
High:5.70
Open:5.61
Low:5.31
Close:5.64
52wk High:8.90
52wk Low:2.25
Shares:128.92M
Float Shares:102.00M
Volume Ratio:0.65
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0800
EPS(LYR):-3.0800
ROE:-565.28%
ROA:-51.68%
PB:-13.10
PE(LYR):-1.74

Loading ...

Compass Pathways to Attend TD Cowen 46th Annual Healthcare Conference in Boston

Reuters
·
Feb 24

Compass Pathways PLC expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Feb 23

Compass Pathways Shares Reverse Premarket Course; Last Down 4.4%

THOMSON REUTERS
·
Feb 19

Shares of Compass Pathways up 2.6% Premarket After Co Announces $150 Mln Equity Raise

THOMSON REUTERS
·
Feb 19

BUZZ-Compass Pathways climbs premarket after $150 mln equity raise

Reuters
·
Feb 19

Compass Pathways Prices $150 Million Public Offering

MT Newswires Live
·
Feb 19

BRIEF-Compass Pathways Announces Pricing Of $150 Million Public Offering

Reuters
·
Feb 19

Compass Pathways Plc - Prices Public Offering of 17.5 Mln Ads at $8.00 per Ads

THOMSON REUTERS
·
Feb 19

Compass Pathways Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 19

Compass Pathways Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Feb 19

European Equities Traded in the US as American Depositary Receipts Higher Wednesday

MT Newswires Live
·
Feb 19

BUZZ-Compass Pathways extends rally after psychedelic depression treatment's late-stage study win

Reuters
·
Feb 18

Compass Pathways announces $150M American Depositary Shares offering

TIPRANKS
·
Feb 18

Compass Pathways Launches Proposed $150.0 Million Public Offering

THOMSON REUTERS
·
Feb 18

Top Midday Gainers

MT Newswires Live
·
Feb 18

Compass Pathways Plc : TD Cowen Raises Target Price to $29 From $23

THOMSON REUTERS
·
Feb 17

Robust Phase 3 Efficacy and Clean Safety Profile Drive Buy Rating on COMPASS Pathways’ CMPS

TIPRANKS
·
Feb 17

BUZZ-U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital

Reuters
·
Feb 17

COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy

Benzinga_recent_news
·
Feb 17

Analysts Conflicted on These Healthcare Names: Sensus Healthcare (SRTS), NeoGenomics (NEO) and COMPASS Pathways (CMPS)

TIPRANKS
·
Feb 17